Evidence map›Paper›PMID 10980130›Full record

ArticleThe American journal of pathology2000

Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.

S K Singhrao, J W Neal, N K Rushmere, B P Morgan, P Gasque

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 134 citations in OpenAlex.

  1. Review
  2. The complement system in neurodegenerative diseases.Clinical science (London, England : 1979) · 2024
    Article
  3. The Role of Complement Dysregulation in Glaucoma.International journal of molecular sciences · 2024
    Review
  4. Journal of Alzheimer's disease reports · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Review
  13. Article
  14. Review
  15. Review
  16. ChronicJournal of oral microbiology · 2017
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

S K SinghraoDepartment of Medical Biochemistry, Brain Inflammation and Immunity Group, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom. singhrao@cardiff.ac.uk
J W Neal
N K Rushmere
B P Morgan
P Gasque
Institute of Infection and Immunity · CAUniversity of Wales · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

This study investigated the capacity of neurons and astrocytes to spontaneously activate the complement system and control activation by expressing complement regulators. Human fetal neurons spontaneously activated complement through the classical pathway in normal and immunoglobulin-deficient serum and C1q binding was noted on neurons but not on astrocytes. A strong staining for C4, C3b, iC3b neoepitope and C9 neoepitope was also found on neurons. More than 40% of human fetal neurons were lysed when exposed to normal human serum in the presence of a CD59-blocking antibody, whereas astrocytes were unaffected. Significant reduction in neuronal cell lysis was observed after the addition of soluble complement receptor 1 at 10 microg/ml. Fetal neurons were stained for CD59 and CD46 and were negative for CD55 and CD35. In contrast, fetal astrocytes were strongly stained for CD59, CD46, CD55, and were negative for CD35. This study demonstrates that human fetal neurons activate spontaneously the classical pathway of complement in an antibody-independent manner to assemble the cytolytic membrane attack complex on their membranes, whereas astrocytes are unaffected. One reason for the susceptibility of neurons to complement-mediated damage in vivo may reside in their poor capacity to control complement activation.

Indexed as

Antibodies, BlockingAntigens, CDAstrocytesBrainCells, CulturedComplement ActivationComplement C3-C5 ConvertasesComplement Inactivator ProteinsComplement Pathway, ClassicalFetusFluorescent Antibody Technique, IndirectHumansImage Processing, Computer-AssistedIn Situ HybridizationMembrane Cofactor ProteinMembrane GlycoproteinsAntibodies, BlockingAntigens, CDCD46 protein, humanComplement C3-C5 ConvertasesComplement Inactivator ProteinsMembrane Cofactor ProteinMembrane GlycoproteinsReceptors, ComplementRNARNA, Messenger

Identifiers

PMID10980130
PMCPMC1885712
OpenAlexW2081767887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.